KET-MCI: An open-label trial of single-dose ketamine treatment to improve depression in mild cognitive impairment

Authors
Category Primary study
ConferenceAlzheimer's Association International Conference, AAIC 2024
Year 2024
This article has no abstract
Epistemonikos ID: b624a85a87aab66db4c4aa1fd3af12439a9693f2
First added on: Oct 25, 2025